Rx Palladia 50 mg x Single Tablet

Palladia (toceranib phosphate) is a veterinary prescription tyrosine kinase inhibitor (TKI) and the first FDA-approved oral chemotherapy for dogs. It is indicated for the treatment of cutaneous mast cell tumors (MCTs), with or without regional lymph node involvement. Palladia works by blocking the growth signals of cancer cells, helping to shrink tumors and slow disease progression.

Key Details:

• Strength & Count: 50 mg tablet; Single Tablet.

• Class: Antineoplastic (tyrosine kinase inhibitor).

• Indication (Dogs): Treatment of mast cell tumors in dogs.

• Canine/Feline/Other Species Safety: Approved for dogs only. Not approved for cats, horses, or other animals.

• Use Only Under Vet Supervision: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Chemotherapy medicationhandle with care. Not for human use.

• Contraindications/Cautions: Do not use in breeding, pregnant, or lactating dogs. Use cautiously in dogs with gastrointestinal conditions, hypertension, or liver/kidney impairment. Side effects may include vomiting, diarrhea, inappetence, lameness, or weight loss. Routine monitoring of bloodwork is required during treatment.

• Storage: Store at 5986F (1530C). Keep in the original container. Protect from moisture and light.

Regulatory: Prescription required; federal law restricts this drug to use by or on the order of a licensed veterinarian.

Keep away from children and other household pets.
This item is not returnable or refundable.

Sold in Qty. of 1 (Single Tablet).

Product type: Animal Health & Wellness > Medicine Brand: Palladia Size: 50mg x Single Status: Available Animal type: Dog Storage & Disposal: Store at controlled room temperature 20 to 25 C (68 to 77 F). Cautions & Warnings: PALLADIA may cause vascular dysfunction which can lead to edema and thromboembolism including pulmonary thromboembolism. Discontinue drug until clinical signs and clinical pathology have normalized. To assure vasculature homeostasis wait at least 3 days after stopping drug before performing surgery. Do not use in dogs used for breeding or for pregnant or lactating bitches. Potential Side Effects: Diarrhea appetite loss lameness weight loss bloody stool. Serious and sometimes fatal gastrointestinal complications including gastrointestinal perforation have occurred rarely in dogs treated with PALLADIA (see Adverse Reactions). If gastrointestinal ulceration is suspected stop drug administration and treat appropriately. Dosage instructions: Administer an initial dosage of 3.25 mg/kg (1.48 mg/lb) body weight orally every other day (see Table 1). Dose reductions of 0.5 mg/kg (to a minimum dose of 2.2 mg/kg (1.0 mg/lb) every other day) and dose interruptions (cessation of PALLADIA for up to two weeks) may be utilized if needed to manage adverse reactions (see Table 2 as well as Warnings and Precautions). Adjust dose based on approximately weekly veterinary assessments for the first 6 weeks and approximately every 6 weeks thereafter. PALLADIA may be administered with or without food. Do not split tablets. Weight: 1.00 Prescription required: YES